Press "Enter" to skip to content

Panacea Biotec launches generic diabetes treatment drug in India

By Admin on December 11, 2019

Vildagliptin product patent in India has expired on December 9, 2019 , the company said.

Original source: https://health.economictimes.indiatimes.com/news/pharma/panacea-biotec-launches-generic-diabetes-treatment-drug-in-india/72455614?utm_source=RSS&utm_medium=ETRSS

Also Read:   Insys to pay $225 million, plead guilty in U.S. over opioid kickbacks

Published in Industry News

Admin
Admin

More from Industry NewsMore posts in Industry News »